Role of pharmacist in providing drug information and education for patients with chronic diseases during Transition of Care
Author:
Athiyah Umi1, Rahem Abdul1, Setiawan Catur Dian1, Hermansyah Andi1
Affiliation:
1. Universitas Airlangga, Surabaya, Indonesia
Abstract
Introduction: Community pharmacist can play an active role in improving care for recently discharged patient through provision of information and education and more importantly prevent readmission to hospital.
Aim: This study aims to investigate the impact of pharmacist providing drug information and education for discharged patient with chronic disease.
Methods: A survey was conducted between July to October 2019 involving 153 patients with hypertension and diabetes mellitus. Patients were purposively recruited from 11 pharmacies in East Java. A questionnaire was used to record patient’s opinion regarding provision of drug information and education by pharmacist. The results were descriptively analysed.
Results: Overall, patients mentioned that pharmacists mainly provided information about how to use the drugs (83%). The education provided by the pharmacist has improved patients’ understanding about their disease state (70%) and influenced the compliance when using the medicine (68%). Patients acknowledged pharmacist’s effort to ensure the positive outcome of the therapy. However, no data has been recorded whether such service may prevent patients from being readmitted to hospital.
Conclusion: Pharmacist is at unique position in the transitions of care. Pharmacist can provide information and education that may contribute to improve patient’s understanding and compliance.
Publisher
International Pharmaceutical Federation (FIP)
Subject
Pharmaceutical Science,Pharmacy,Education
Reference33 articles.
1. Alghamdi, M.A., Shihab, T.A., Hilabi, M.A., Alqaaiyan, S.A., Alzain, W.I., Alhumaidan, A.M., Alfageeh, K.K.A. (2017). Compliance of Type 2 Diabetic Patients to Its Management : A Cross-Sectional Survey, 3(1), 146–152. https://doi.org/10.21276/ijmrp.2017.3.1.028 2. Alhossan, A., & Alazba, A. (2019). Barriers interfering with establishment of Collaborative Drug Therapy Management (CDTM) agreements between clinical pharmacists and physicians. Saudi Pharmaceutical Journal, 27(5), 713–716. https://doi.org/10.1016/j.jsps.2019.04.006 3. AlRuthia, Y., Alkofide, H., Alosaimi, F. D., Sales, I., Alnasser, A., Aldahash, A., Almutairi L,. AlHusayni, M.M., Alanazi, M.A. (2019). Drug-drug interactions and pharmacists’ interventions among psychiatric patients in outpatient clinics of a teaching hospital in Saudi Arabia. Saudi Pharmaceutical Journal, 27(6), 798–802. https://doi.org/10.1016/j.jsps.2019.05.001 4. Athiyah, U., Rahem, A., & Setiawan, C.D. (2019). The Influence of Participation of the Social Security Agency (BPJS) Health on Therapeutic Success in Hypertension Patients at Community Health Centers. Research Journal of Pharmacy and Technology, 12(1), 93-98. https://doi.org/10.5958/0974-360x.2019.00018.0 5. Badreldin, H.A., Raslan, S., Almudaiheem, H., Alomari, B., Almowaina, S., Joharji, H., Alawagi, M., Al-jedai, A. (2020). Pharmacists roles and responsibilities during epidemics and pandemics in Saudi Arabia: An opinion paper from the Saudi Society of clinical pharmacy. Saudi Pharmaceutical Journal, 28(8), 1030–1034. https://doi.org/10.1016/j.jsps.2020.07.002
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|